17% with placebo, though fibrosis stage did not significantly improve
In March 2026, the FDA sent warning letters to 30 telehealth companies for illegally marketing compounded GLP-1 drugs
Their study concluded that this is evidence that when GLP-1 was added to isolated human islets it was found that it inhibits cell apoptosis
Storage conditions are governed by the trial sponsor's Pharmacy Manual, the IMP label, and UK Good Clinical Practice not a public SmPC
99% purity) can invalidate long-term data
In mouse models of Alzheimers disease synthetic incretin hormones exerted neuroprotective effects, including reduced amyloid plaque load, reducing oxidative stress and the chronic inflammatory response in the brain, and enhancing neurogenesis (72, 73)